Successful management of critical illness polyneuropathy and myopathy in renal transplant recipients

Experimental and Clinical Transplantation

Volumn 10, Issue 1, 2012, Pages 62-66

  Gheith, Osama ^a   Al Otaibi, Torki ^a   Abdelhalim, Medhat ^a   Said, Tarek ^a   Nair, Prasad ^a   Balaha, Mohamed ^a   Abd el Tawab, Khalid ^a   Zakareya, Zakareya ^a   Hosni, Waleed ^a   Narayanan Nampoory, M R ^a  

^a IBN SINA HOSPITAL   (Kuwait)

Author keywords

Critical illness; Polyneuropathy; Renal transplant

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BRONCHOPNEUMONIA; CLINICAL ARTICLE; CRITICAL ILLNESS; DRUG BLOOD LEVEL; EARLY DIAGNOSIS; ELECTROMYOGRAPHY; FEMALE; FLACCID PARALYSIS; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; MYOPATHY; PLASMAPHERESIS; POLYNEUROPATHY; SINGLE DRUG DOSE; TENDON REFLEX;

ADULT; AGED; BRONCHOPNEUMONIA; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERGLYCEMIA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MUSCULAR DISEASES; PATIENT CARE MANAGEMENT; POLYNEUROPATHIES; RENAL INSUFFICIENCY; RISK FACTORS; TRANSPLANTATION; VENTILATORS, MECHANICAL;

EID: 84856944250     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2011.0073     Document Type: Article

References (27)

1. Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry. 1984;47(11):1223-1231.
2. Roelofs RI, Cerra F, Bielka N, Rosenberg L, Delaney J. Prolonged respiratory insufficiency due to acute motor neuropathy: a new syndrome? Neurology. 1983;33:240.
3. Zochodne DW, Bolton CF, Wells GA, et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain. 1987;110(Pt 4):819-841.
4. Bolton CF, Young GB, Zochodne DW. The neurological complications of sepsis. Ann Neurol. 1993;33(1):94-100.
5. Dussoix P, Chevrolet JC, Cox J, Pizzolato G, Magistris MR. Secondary neuromyopathies in a resuscitation unit [in French]. Réanimation Urgences. 1993;2(3):247-258.
6. Rivner MH, Kim S, Greenberg M, Swift TR. Reversible generalized paresis following hypertension: a new neurological entity. Neurology. 1983;33:164.
7. Wilmshurst PT, Treacher DF, Lantos PL, Wiles CM. Critical illness poly-neuropathy following severe hyperpyrexia. QJM. 1995;88(5):351-355.
8. Bednarik J, Vondracek P, Dusek L, Moravcova E, Cundrle I. Risk factors for critical illness polyneuromyopathy. J Neurol. 2005;252(3):343-351.
9. Garnacho-Montero J, Madrazo-Osuna J, García-Garmendia JL, et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med. 2001;27(8):1288-1296.
10. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005;64(8):1348-1353.
11. Witt NJ, Zochodne DW, Bolton CF, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest. 1991;99(1):176-184.
12. Khan J, Harrison TB, Rich MM, Moss M. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology. 2006;67(8):1421-1425.
13. Latronico N, Bertolini G, Guarneri B, et al. Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: the Italian multi-centre CRIMYNE study. Crit Care. 2007;11(1):R11.
14. Stibler H, Edström L, Ahlbeck K, Remahl S, Ansved T. Electrophoretic determination of the myosin/actin ratio in the diagnosis of critical illness myopathy. Intensive Care Med. 2003;29(9):1515-1527.
15. Vijayan J, Alexander M. Critical illness neuropathy. Indian J Crit Care Med. 2005;9:32-34.
16. Boles JM, Bion J, Connors A, et al. Weaning from mechanical ventilation. Eur Respir J. 2007;29(5):1033-1056.
17. Martin UJ, Hincapie L, Nimchuk M, Gaughan J, Criner GJ. Impact of whole-body rehabilitation in patients receiving chronic mechanical ventilation. Crit Care Med. 2005;33(10):2259-2265.
18. Mohr M, Englisch L, Roth A, Burchardi H, Zielmann S. Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gramnegative sepsis. Intensive Care Med. 1997;23(11):1144-1149.
19. Fletcher SN, Kennedy DD, Ghosh IR, et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med. 2003;31(4):1012-1016.
20. Bérard MP, Zazzo JF, Condat P, Vasson MP, Cynober L. Total parenteral nutrition enriched with arginine and glutamate generates glutamine and limits protein catabolism in surgical patients hospitalized in intensive care units. Crit Care Med. 2000;28(11):3637-3644.
21. Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Clinical review: Critical illness polyneuropathy and myopathy. Crit Care. 2008;12(6):238.
22. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab. 2003;88(3):1082-1088.
23. Langouche L, Vanhorebeek I, Vlasselaers D, et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest. 2005;115(8):2277-2286.
24. Ishii DN, Lupien SB. Insulin-like growth factors protect against diabetic neuropathy: effects on sensory nerve regeneration in rats. J Neurosci Res. 1995;40(1):138-144.
25. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-1367.
26. Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int. 2000;13(5):313-326.
27. Noè A, Cappelli B, Biffi A, et al. High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome. Ital J Pediatr. 2010;36:14.